- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Incannex Healthcare Inc. - S-1/A, General form for registration of securities | 3 | SEC Filings | ||
| 03.04. | Incannex Healthcare Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 03.04. | Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) | 125 | GlobeNewswire (Europe) | NEW YORK and MELBOURNE, Australia, April 03, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company leading the way in developing... ► Artikel lesen | |
| 24.03. | Incannex Healthcare files to sell 65.97M shares of common stock for holders | 1 | Seeking Alpha | ||
| 18.03. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.03. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 07.03. | Incannex Healthcare prices $12.5M private placement | 1 | Seeking Alpha | ||
| INCANNEX HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 07.03. | Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules | 1 | GlobeNewswire (USA) | ||
| 14.02. | Incannex Healthcare Limited Loss At -$5.8 Mln In Q2 | 2 | RTTNews | ||
| 14.02. | Incannex Healthcare Limited Loss At -$5.89 Mln In Q2 | 1 | RTTNews | ||
| 14.02. | Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates | 203 | GlobeNewswire (Europe) | Positive IHL-42X PK findings for the treatment of Obstructive Sleep Apnea (OSA) support future 505(b)(2) New Drug Application (NDA) submissionNew OSA Clinical Advisory Board Announced; Appoints Dr.... ► Artikel lesen | |
| 14.02. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.02. | Incannex Healthcare Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 04.02. | Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board | 1 | GlobeNewswire (USA) | ||
| 04.02. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.01. | Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea | 99 | GlobeNewswire (Europe) | Demonstrated bioavailability of IHL-42X, Incannex's proprietary combination formulation, confirming delivery of both dronabinol and acetazolamideAchieved similar PK and equivalent total drug exposure... ► Artikel lesen | |
| 23.01. | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.01. | Incannex Healthcare Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.12.24 | Incannex Healthcare Inc. - 8-K, Current Report | - | SEC Filings | ||
| 26.11.24 | Incannex Healthcare Inc. - S-1/A, General form for registration of securities | - | SEC Filings |
Seite:
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
Das Unternehmen INCANNEX HEALTHCARE INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,67 % bei einem Aktienkurs von 0,610 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INCANNEX HEALTHCARE INC finden Sie auf Wallstreet Online.
